Abnormal Uterine Bleeding Case Studies

Similar documents
Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018

PCOS and Obesity DUB is better treated by OCPs

Polycystic Ovary Syndrome

What is PCOS? PCOS THE CONQUER PCOS E-BOOK. You'll be amazed when you read this...

POTION OR POISON? MEDICAL TREATMENT ALTERNATIVES TO THE PILL. Lester Ruppersberger, D.O., FACOOG,CNFPI NFP only Gynecologist

Conflicts 10/5/2016. Abnormal Uterine Bleeding. Objectives Review diagnosis and updated nomenclature. Management options for acute and chronic AUB.

PCOS Awareness Symposium Atlanta September 24 th, Preventing Diabetes & Cardiovascular Disease in PCOS

Contraception. Yolanda Evans MD MPH Assistant Professor of Pediatrics Division of Adolescent Medicine

12/27/2013. Kristen Cain, MD FACOG Reproductive Medicine Institute Sanford Health, Fargo ND

Polycystic Ovary Syndrome: Cardiovascular Disease risk

Dr Stella Milsom. Endocrinologist Fertility Associates Auckland. 12:30-12:40 When Puberty is PCO

Polycystic Ovarian Syndrome. Heidi Hallonquist, MD Concord Hospital Concord Obstetrics and Gynecology

Case Questions. Polycystic Ovarian Syndrome: Treatment Goals and Options. Differential Diagnosis of Hyperandrogenic Anovulation

12/13/2017. Important references for PCOS. Polycystic Ovarian Syndrome (PCOS) for the Family Physician. 35 year old obese woman

Cynthia Morris DO, FACOOG, FACOS Medical Director, Women s Wellness Center Fayette County Memorial Hospital

Overview of Reproductive Endocrinology

13 th Annual Women s Health Day PCOS. Saturday 02/09/2017 Dr Mathias Epee-Bekima O&G Consultant KEMH

Dysfunctional Uterine Bleeding

Female Reproductive Endocrinology

UPDATE: Women s Health Issues

Polycystic Ovary Syndrome

Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc)

Amenorrhoea: polycystic ovary syndrome

Polycystic Ovary Syndrome (PCOS):

Primary Care Gynaecology Guidelines: HEAVY REGULAR MENSTRUAL BLEEDING

Abnormal Uterine Bleeding: Evaluation of Premenopausal Women. Vanessa Jacoby, MD, MAS Assistant Professor Ob, Gyn, & Reproductive Sciences UCSF

Polycystic Ovary Syndrome

Managing Menstrual Disorders

Elaina Sexton, MD, MSc Obstetrics and Gynecology St. Vincent s Hospital. Objectives

Frequency of menses. Duration of menses 3 days to 7 days. Flow/amount of menses Average blood loss with menstruation is 60-80cc.

Topics. Periods Menopause & HRT Contraception Vulva problems

Polycystic Ovarian Syndrome (PCOS) LOGO

Case. 24 year old female presented to your office complaining of excess hair growth on her face and abdomen. Questions?

CASE 4- Toy et al. CASE FILES: Obstetrics & Gynecology

PCOS IN ADOLESCENTS: EARLY DETECTION AND INTERVENTION

5/5/2010 FINANCIAL DISCLOSURE. Abnormal Uterine Bleeding. Is This A Problem? About me % of visits to gynecologist

16 YEAR-OLD OBESE FEMALE WITH OLIGOMENORRHEA

Abnormal Uterine Bleeding

Dr. Nancy Van Eyk Associate Professor, Dalhousie University Chief of Gynaecology, IWK Health Centre

Dr Mary Birdsall. Fertility Associates Auckland

OVERVIEW. FEMM (Fertility Education & Medical Management) is headquartered in New York City, NY. 1

F REQUENTLY A SKED Q UESTIONS

Polycystic Ovary Syndrome

PCOS The intersection of sex hormones & metabolism. Educational Objectives. Presenter Disclosure Information. Polycystic Ovary Syndrome

ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU)

Ohio Northern University HealthWise. Authors: Alexis Dolin, Andrew Duska, Hannah Lamb, Eric Miller, Pharm D Candidates 2018 May 2018

POLYCYSTIC OVARIAN SYNDROME Laura Tatpati, MD Reproductive Endocrinology and Infertility. Based on: ACOG No. 108 Oct 2009; reaffirmed 2015

The Impact of Insulin Resistance on Long-Term Health in PCOS


POLYCYSTIC OVARIAN SYNDROME WHERE WE ARE AT IN 2018

Chapter 100 Gynecologic Disorders

Adolescent Gynecology: Evaluation and Management of Adnexal Mass, PCOS, and Endometriosis. Shanna M. Combs, MD

New PCOS guidelines: What s relevant to general practice

Polycystic ovary syndrome

of AUB DISCLOSURES 10/29/2018

What s New in Adolescent Contraception?

Sexual dysfunction of chronic kidney disease. Razieh salehian.md psychiatrist

Healthcare Education Research

PCOS guidelines: What s relevant to general practice

Estrogen Dominant Conditions Part I

PERIMENOPAUSE. Objectives. Disclosure. The Perimenopause Perimenopause Menopause. Definitions of Menopausal Transition: STRAW.

Month-Long Hormone Assessment: What goes up must come down. Disclaimer. Aims and Objectives. George Gillson MD PhD

Prevalence of Polycystic Ovarian Syndrome among urban adolescent girls and young women in Mumbai

Infertility for the Primary Care Provider

10/24/2017. Financial Disclosure. Financial Disclosure

By Jennifer F. Teskey, MD; Heather J. Dean, MD, FRCPC; and Elizabeth AC Sellers, MSc, MD, FRCPC. amenorrhea. Following menarche 3. How to treat PCOS.

Test Results SB Samples Arrived: 01/15/2014 Samples Collected: Saliva: 01/11/14 07:14 Date Closed: 01/18/2014

What every dermatologist should know about Polycystic Ovary Syndrome (PCOS)

Infertility History Form

CREATING A PCOS TREATMENT PLAN. Ricardo Azziz, M.D., M.P.H., M.B.A. Georgia Regents University

Prof.Dr. Nabil Lymon Head of Internal Medicine Department

Polycystic Ovary Disease: A Common Endocrine Disorder in Women

Disclosure. Outline. Obesity: Endocrine Issues as the Cause and as the Effect 4/5/2016

PCOS. Kirtly Parker Jones MD

Dysfunctional Uterine Bleeding (DUB) OB/GYN Hospital of Fudan University Weiwei Feng, MD,Ph D Tel:

Polycystic Ovary Syndrome

Puberty and Fertility. Normal Female Puberty PUBERTY! What about girls with Galactosemia? E Puberty and Fertility Badik Spencer 1

Hyperandrogenism. Dr Jack Biko. MB. BCh (Wits), MMED O & G (Pret), FCOG (SA), Dip Advanced Endoscopic Surgery(Kiel, Germany)

REI CASE(S) Laura L. Tatpati, MD Division of REI, Dept of OB/GYN KUSM - W

International Journal of Current Medical And Applied Sciences.vol.1. Issue: 1, 2013, PP 11-15

Why do I need any hormone replacement? What is Menopause? What symptoms are treated by estrogen Injections?

PCOS. Reproductive Gynaecology and Infertility. Dr.Renda Bouzayen MD.FRCSC GREI,OBGYN Dalhousie University

5 Mousa Al-Abbadi. Ola Al-juneidi & Obada Zalat. Ahmad Al-Tarefe

Polycystic Ovary Syndrome (PCOS)

What is polycystic ovary syndrome? What are polycystic ovaries? What are the symptoms of PCOS?

Reproductive Health and Pituitary Disease

Reproductive Testing: Less is More G. Wright Bates, Jr., M.D. Professor and Director Reproductive Endocrinology and Infertility Objectives

Difference Between PCOS and Endometriosis

Polycystic ovary syndrome (PCOS)

DOWNLOAD PDF A GUIDE TO THE POLYCYSTIC OVARY

lactotrophs 120 min- FSH 60 min- LH Hypothalamus GnRH pituitary Estradiol +/- Progesterone _ FSH L H Ovary Uterus Ovulation Antral follicle >2mm

CLEAR COVERAGE HYSTERECTOMY CHECKLISTS

Index. Note: Page numbers of article titles are in boldface type.

INFERTILITY CAUSES. Basic evaluation of the female

SAMPLE REPORT. Order Number: PATIENT. Age: 40 Sex: F MRN:

Ardhanu Kusumanto Oktober Contraception methods for gyne cancer survivors

Abnormal vaginal bleeding is a common complaint. Abnormal Uterine Bleeding in Reproductive- Aged Women. Case-based review

S. AMH in PCOS Research Insights beyond a Diagnostic Marker

FDA-Approved Patient Labeling Patient Information Mirena (mur-ā-nah) (levonorgestrel-releasing intrauterine system)

Addressing Practice Gaps in PCOS

Transcription:

Case Study 1 Abnormal Uterine Bleeding Case Studies Abigail, a 24 year old female, presents to your office complaining that her menstrual cycles have become a problem. They are now lasting 6 7 days instead of 3 4, and come every 30 days instead of every 26 days. She has no pain, cramping, or vaginal discharge. She has never missed a menstrual cycle. She has not been sexually active for over 6 months. Her past medical history is remarkable only for severe reflux disease for which she takes daily prilosec. 2 Q1: The information you want most from her is: A. How many tampons/pads she uses in a 24 hour period B. Whether or not she is passing clots C. Whether or not she is missing work or avoiding social activities because of her menses D. If she has a family history of fibroids E. If she has a family history of PCOS Q1: The information you want most from her is: A. How many tampons/pads she uses in a 24 hour period B. Whether or not she is passing clots C. Whether or not she is missing work or avoiding social activities because of her menses D. If she has a family history of fibroids E. If she has a family history of PCOS 3 4 Tampon and pad counts are not reliable indicators of actual blood loss Questions to ascertain the impact of the bleeding include: Does the bleeding interfere with her sex life? Does she have to leave work or class due to heavy bleeding? Are there things she doesn t due because of her periods? Q2: The most useful set of laboratory tests to order for evaluating Abigail would be: A. CBC, testosterone level, and Von Willebrand s screen B. Ferritin, TSH, pregnancy test C. VonWillebrand s screen, ferritin D. Urine pregnancy test, prolactin, and TSH E. Ferritin, prolactin, urine pregnancy test 5 6 1

Q2: The most useful set of laboratory tests to order for evaluating Abigail would be: A. CBC, testosterone level, and Von Willebrand s screen B. Ferritin, TSH, pregnancy test C. VonWillebrand s screen, ferritin D. Urine pregnancy test, prolactin, and TSH E. Ferritin, prolactin, urine pregnancy test Check hemoglobin/hematocrit for anemia and ferritin for iron deficiency Rule out pregnancy with a urine test Von Willebrand disease is the most common coagulation disorder causing menorrhagia; not usually checked unless there are other signs of bleeding or in an adolescent Remember hypothyroidism presents with heavy menses and should always be ruled out 7 8 Case Study 1, continued Q3: The best alternative strategy for managing her cycles includes: All laboratory tests return normal. You find out that Abigail is missing work 1 2 days per month and is avoiding social activities during the first three days of her period. She adamantly refuses to consider combination hormonal contraception. A. Reassurance B. Iron supplementation C. Tylenol during her menstrual cycles D. Daily ibuprofen from the beginning of her menstrual cycle through the end of her menses E. Contraception containing progesterone only 9 10 Q3: The best alternative strategy for managing her cycles includes: A. Reassurance B. Iron supplementation C. Tylenol during her menstrual cycles D. Daily ibuprofen from the beginning of her menstrual cycle through the end of her menses E. Contraception containing progesterone only The appropriate management depends on the patient s medical history, risks, and personal choices If contraception is desired, either combination contraception or progesterone only contraception would be indicated If she is unable to take estrogen (i.e., clotting risk), a progesterone only contraception is appropriate If a woman does not desire contraception, or doesn t want to take any hormones, NSAIDs alone may be enough 11 12 2

Case Study 2 Olivia, a 51 year old female, presents to you with complaints of heavy menstrual bleeding. She complains of 6 weeks of bleeding all the time. She cannot be more specific about her menstrual bleeding pattern. She is fatigued. On further questioning, she endorses increased sweating, palpitations, and insomnia. Q4. Labs that would be most helpful include: A. TSH, ferritin, and FSH B. Urine pregnancy test, ferritin, and TSH C. FSH and urine pregnancy test D. FSH, LH and estradiol E. FSH, LH, and TSH 13 14 Q4. Labs that would be most helpful include: A. TSH, ferritin, and FSH B. Urine pregnancy test, ferritin, and TSH C. FSH and urine pregnancy test D. FSH, LH and estradiol E. FSH, LH, and TSH Any woman with a history of abnormal menses should have a urine pregnancy test Check ferritin for iron deficiency and as a means to quantify the bleeding Check TSH for hypothyroidism In the perimenopause (which would be the case with this woman), the FSH and estradiol levels fluctuate from month to month and would not offer any information beyond the clinical scenario 15 16 Q5. You conclude that Olivia is perimenopausal. Which of the following would make you MOST likely to recommend that she undergo an endometrial aspirate to rule out endometrial carcinoma as an etiology of her erratic bleeding? A. Her age B. A long history of oral contraceptive use C. A history of polycystic ovarian syndrome with anovulatory cycles D. A history of fibroids Q5. You conclude that Olivia is perimenopausal. Which of the following would make you MOST likely to recommend that she undergo an endometrial aspirate to rule out endometrial carcinoma as an etiology of her erratic bleeding? A. Her age B. A long history of oral contraceptive use C. A history of polycystic ovarian syndrome with anovulatory cycles D. A history of fibroids 17 18 3

Late consequences of Polycystic Ovarian Syndrome include endometrial cancer due to anovulatory cycles and prolonged exposure to unopposed estrogen Age is certainly a risk factor for endometrial cancer; above 40 increases the risk but in this case is not the MOST worrisome feature The same is true for obesity Fibroids confer no increased risk; OCP use is actually protective Q6. Appropriate management for Olivia s symptoms of abnormal bleeding in the perimenstrual time period include all EXCEPT: A. Combination hormonal contraception B. Combination postmenopausal hormone therapy with estradiol and medroxyprogesterone acetate C. Intermittent medroxyprogesterone acetate D. Mirena IUD 19 20 Q6. Appropriate management for Olivia s symptoms of abnormal bleeding in the perimenstrual time period include all EXCEPT: A. Combination hormonal contraception B. Combination postmenopausal hormone therapy with estradiol and medroxyprogesterone acetate C. Intermittent medroxyprogesterone acetate D. Mirena IUD A combined estrogen/progestin contraceptive such as the pill, patch, or intravaginal ring will provide enough hormone to shut down the ovaries and thus control the bleeding by regulating the cycle Hormone therapy in a patient who is still intermittently ovulating does not suppress ovarian function; thus HT plus normal cycling may actually make perimenopausal bleeding worse Levonorgestrel (Mirena) IUD and intermittent medroxyprogesterone acetate will thin the uterine lining and thus diminish bleeding 21 22 Case Study 3 Susan, a 24 year old female, presents to your office with a longstanding history of irregular menstrual cycles. She can go months at a time without a menstrual cycle and then will bleed for 20 days. Q7. You are considering a diagnosis of polycystic ovarian syndrome. Which would be most helpful in making the diagnosis? A. A family history of PCOS B. The knowledge that her menstrual cycles became regular on combination hormonal contraception C. A history of infertility D. A history of acne and hirsutism 23 24 4

Q7. You are considering a diagnosis of polycystic ovarian syndrome. Which would be most helpful in making the diagnosis? A. A family history of PCOS B. The knowledge that her menstrual cycles became regular on combination hormonal contraception C. A history of infertility D. A history of acne and hirsutism Diagnosis of PCOS Rotterdam Criteria: Two of Three (2003) Clinical or biochemical evidence of hyperandrogenism (so in this case her acne and hirsutism meet this criteria for diagnosis along with irregular menstrual cycles) Oligo ovulation or anovulation (<9 periods/year) Presence of polycystic ovaries on pelvic ultrasound NOTE: Does NOT include obesity or insulin resistance or family history; everyone will regulate their menstrual cycles on OCPs 25 26 Q8. You make a diagnosis of PCOS in Susan based on an elevated serum testosterone level. You recommend: A. Starting oral contraceptives B. Starting metformin and oral contraceptives C. Starting metformin alone D. Starting spironolactone E. Mirena IUD Q8. You make a diagnosis of PCOS in Susan based on an elevated serum testosterone level. You recommend: A. Starting oral contraceptives B. Starting metformin and oral contraceptives C. Starting metformin alone D. Starting spironolactone E. Mirena IUD 27 28 Case Study 3, continued Combination contraception is first line treatment Susan needs contraception if she does not desire pregnancy. OCPs provide endometrial protection plus contraception. OCPs also increase SHBG and thus decrease signs of excess androgen. Metformin is FDA approved for type 2 diabetes It has been used off label to treat the following in PCOS: Oligomenorrhea (combination estrogen progestin contraceptives are firstline treatment) Obesity Hirsutism combination estrogen progestin contraceptives are first line treatment (2008 Endocrine Society Guidelines) Prevention of type 2 diabetes mellitus (not for women with normal glucose tolerance) After regulating her menstrual cycles and managing her hirsutism, you begin thinking about Susan s overall health and long term risks of disease. She is about 20 pounds overweight, so first and foremost you recommend weight loss. 29 30 5

Q9. Other recommendations, at a minimum, that you would make include: Q9. Other recommendations, at a minimum, that you would make include: A. Fasting lipid profile B. Fasting lipid profile and a hemoglobin A1C C. Fasting lipid profile and a sleep study to rule out sleep apnea D. Fasting lipid profile and a pelvic ultrasound to evaluate endometrial lining thickness E. Nothing other than weight loss at this time A. Fasting lipid profile B. Fasting lipid profile and a hemoglobin A1C C. Fasting lipid profile and a sleep study to rule out sleep apnea D. Fasting lipid profile and a pelvic ultrasound to evaluate endometrial lining thickness E. Nothing other than weight loss at this time 31 32 Screen all women with PCOS for the metabolic syndrome and diabetes, which is especially important in this patient since she is overweight Need a fasting lipid profile to screen for the metabolic syndrome Screen for diabetes with either a GTT or a hemoglobin A1C; a fasting glucose alone is not enough It s a good idea to ask about symptoms of sleep apnea even in women with normal BMIs No need to check endometrial lining in a woman this young 33 6